Randal W. Scott, Director at BridgeBio Pharma, Inc. (BBIO), sold 10,000 shares at $66.69 ($671K) on 2026-05-15, disclosed to the SEC on 2026-05-19.
Scheduled sale ($671k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.69 | 6,200 | $413K | 61.6% |
| 2 | $67.53 | 2,088 | $141K | 21.0% |
| 3 | $68.23 | 1,512 | $103K | 15.4% |
| 4 | $69.12 | 200 | $14K | 2.1% |
| Total | $67.15 avg | 10,000 | $671K | 100% |
| Filing → |
| BBIO | SELL | 2024-06-05 | $76K | — | Filing → |
| BBIO | SELL | 2024-03-05 | $85K | — | Filing → |
| BBIO | SELL | 2023-12-20 | $80K | — | Filing → |